Basic Information
| LncRNA/CircRNA Name | SPRY4-IT1 |
| Synonyms | SPRY4-IT1, SPRIGHTLY |
| Region | NA |
| Ensemble | ENSG00000281881 |
| Refseq | NR_131221 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR, Western blot |
| Sample | hepatocellular carcinoma tissues, cell lines (MHCC97L, MHCC97H, HepG2 and SMMC7721, HL7702) |
| Expression Pattern | up-regulated |
| Function Description | high expression of SPRY4-IT1 was associated with poor 5-year overall survival in the HCC patient cohort.the expression of SPRY4-IT1 was significantly correlated with TNM stage in HCC patients. knock-down of SPRY4-IT1 suppressed cell proliferation, colony formation, cell invasion and migration in HCC cells.knock-down of SPRY4-IT1 induced cell cycle arrest at G0/G1 phase and induced apoptosis. knock-down of SPRY4-IT1 also suppressed the mRNA and protein expression of estrogen-related receptor a (ERRa).knock-down of ERRa inhibited cell proliferation, colony formation, cell invasion and migration in HCC cells. More importantly, ERRa overexpression antagonized the effects of SPRY4-IT1 knock-down on cell proliferation, colony formation, cell invasion and migration in HCC cells. |
| Pubmed ID | 29214989 |
| Year | 2017 |
| Title | Long non-coding RNA SPRY4-IT1 promotes development of hepatic cellular carcinoma by interacting with ERRa and predicts poor prognosis. |
External Links
| Links for SPRY4-IT1 | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |